Awarded
1 - L1_ELTROMBOPAG (DOE) 25 mg y 50 mg
Track this recordFree account — get alerted when a contract here runs out.
- Winners
- CIPLA EUROPE NV Sucursal en España, GLENMARK FARMACÉUTICA, S.L.U., KERN PHARMA, S.L., REDDY PHARMA IBERIA,S.A, TARBIS FARMA SL, TEVA PHARMA, S.L., VIATRIS PHARMACEUTICALS, S.L., VIVANTA GENERICS S.R.O. SUCURSAL EN ESPAÑA
- Contract value
- €147,840
- Bids received
- 8
- Published
- 7 Apr 2026
- Awarded
- 1 Apr 2026
- Contract start
- 1 Apr 2026
- Contract end
- 2 Apr 2027estimated
- Region
- Araba/Álava